What were the main drivers of the sales increase in Q1 2004?

The 15% increase in net sales to $8.1 billion was primarily driven by higher sales volumes (7%), a favorable currency impact (6%), and the contribution from acquired businesses (2%).

What are the significant charges impacting the company's profitability in this quarter?

The company incurred substantial special charges totaling $296 million in Q1 2004. Key charges include $150 million for DuPont Dow Elastomers LLC antitrust litigation, $345 million related to the separation of the Textiles & Interiors (INVISTA) segment, and $36 million for Automotive Refinish litigation settlement.

How has the company's debt position changed, and what are the plans for using proceeds from the INVISTA sale?

Consolidated net debt increased to $8.3 billion as of March 31, 2004. The company expects to use the proceeds from the sale of INVISTA to strengthen its balance sheet by reducing debt.

Are there any significant ongoing legal or environmental matters that investors should be aware of?

Yes, the company continues to address several significant matters, including ongoing litigation related to Benlate® fungicide, PFOA environmental concerns and related class-action lawsuits, and antitrust investigations involving DuPont Dow Elastomers LLC. Additionally, environmental remediation efforts are underway at various sites.

CTA-PB/CTA-PA 10-Q Quarterly Report Q1 FY2004

Summary

E.I. du Pont de Nemours and Company (EIDP) reported a significant increase in net sales for the first quarter of 2004, reaching $8.1 billion, up 15% from the prior year's $7.0 billion. This growth was driven by higher sales volumes (7%), currency benefits (6%), and acquired businesses (2%). While net income rose to $668 million from $535 million, the quarter was impacted by substantial special charges, including $150 million for DuPont Dow Elastomers LLC antitrust litigation and $345 million related to the separation of the Textiles & Interiors segment (INVISTA). These charges, along with others, resulted in a diluted EPS of $0.66, compared to $0.53 in the prior year, with reported EPS being higher than pro forma EPS due to stock-based compensation accounting. The company's balance sheet shows total assets of $38.8 billion and total liabilities of $28.1 billion as of March 31, 2004. Cash used for operations was $282 million, with a significant increase in net debt to $8.3 billion, partly due to seasonal working capital needs in the Agriculture & Nutrition segment. The company also announced subsequent events including a significant cost reduction initiative involving a 6% workforce reduction and a $1.4 billion debt offering to refinance existing maturities.

Key Highlights

1Net sales increased by 15% to $8.1 billion in Q1 2004, driven by volume, currency, and acquisitions.
2Net income rose to $668 million, or $0.66 per diluted share, from $535 million ($0.53 per diluted share) in Q1 2003.
3The company recorded significant special charges totaling $296 million in Q1 2004, including $150 million for DuPont Dow Elastomers LLC litigation and $345 million for the INVISTA separation.
4Cost of Goods Sold as a percentage of net sales decreased to 71% from 74% in the prior year, benefiting from the absence of depreciation on divested assets and favorable exchange rates.
5Research and Development expenses increased by nearly 7% to $337 million, aligning with the company's annual R&D budget.
6Consolidated net debt increased to $8.3 billion as of March 31, 2004, despite plans to use proceeds from the INVISTA sale to reduce debt.
7Subsequent to the quarter, DuPont announced a workforce reduction of 3,500 positions as part of a broader cost improvement program.

EIDP, Inc. Quarterly Report for Q1 Ended Mar 31, 2004

Summary

Key Highlights

Frequently Asked Questions